Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza for Post-Vitrectomy Pain and Inflammation (ADHERE)
NCT04462523Phase 4Completed
- Start
- Jan 2020
- Primary completion
- Mar 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in postoperative pain, post-operative inflammation. Started Jan 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT04462523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462523.